Market Cap
$228.29M
Shares Outstanding
94.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 11, 2000
Round Lot
100
Locale
US
Day Open
$2.41
Day High
$2.47
Day Low
$2.40
Volume
117.6K
VWAP
$2.43
Prev Close
$2.41
Transactions
--
Acc. Volume
--
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Compugen Ltd (CGEN) closed the 2026-09-16 session at $2.41, up 0.00% versus the previous close (+0.00). The stock opened at $2.41 and traded between $2.40 and $2.47 during that session. Session trading volume was 118K shares. The volume-weighted average price (VWAP) is $2.43.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Compugen Ltd has a market capitalization of $228.3 million. CGEN is listed on the XNAS exchange. The company employs approximately 75 people. The recorded listing date is 2000-08-11.
On this page you can find market CGEN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.